BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32603695)

  • 1. Protective effects of tadalafil on prostatic hyperplasia in spontaneously hypertensive rats.
    Shimizu S; Nagao Y; Kataoka T; Kamada S; Shimizu T; Higashi Y; Saito M
    Eur J Pharmacol; 2020 Sep; 882():173313. PubMed ID: 32603695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.
    Shimizu S; Shimizu T; Tsounapi P; Higashi Y; Martin DT; Nakamura K; Honda M; Inoue K; Saito M
    PLoS One; 2015; 10(8):e0133798. PubMed ID: 26308715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of losartan on prostatic hyperplasia in spontaneously hypertensive rats.
    Shimizu S; Nagao Y; Shimizu T; Higashi Y; Karashima T; Saito M
    Life Sci; 2021 Feb; 266():118924. PubMed ID: 33352172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.
    Holmström F; Shimizu S; Shimizu T; Higashi Y; Martin DT; Honda M; Saito M
    Prostate; 2015 Nov; 75(15):1774-82. PubMed ID: 26286428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.
    Saito M; Tsounapi P; Oikawa R; Shimizu S; Honda M; Sejima T; Kinoshita Y; Tomita S
    Sci Rep; 2014 Jan; 4():3822. PubMed ID: 24448152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.
    Morelli A; Sarchielli E; Comeglio P; Filippi S; Mancina R; Gacci M; Vignozzi L; Carini M; Vannelli GB; Maggi M
    J Sex Med; 2011 Oct; 8(10):2746-60. PubMed ID: 21812935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type 5 inhibitor attenuates chronic ischemia-induced prostatic hyperplasia in a rat model.
    Fujii S; Yamashita S; Hayashi N; Goto T; Koyama J; Sato T; Shimada S; Kawasaki Y; Izumi H; Kawamorita N; Mitsuzuka K; Ito A; Arai Y
    Prostate; 2019 Apr; 79(5):536-543. PubMed ID: 30593704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of prazosin and naftopidil on pelvic blood flow and nitric oxide synthase levels in spontaneously hypertensive rats.
    Yono M; Yamamoto Y; Imanishi A; Yoshida M; Ueda S; Latifpour J
    J Recept Signal Transduct Res; 2008; 28(4):403-12. PubMed ID: 18702011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 5 inhibitor suppresses prostate weight increase in type 2 diabetic rats.
    Kobayashi H; Zha X; Nagase K; Inamura S; Taga M; Aoki Y; Ito H; Yokoyama O
    Life Sci; 2022 Jun; 298():120504. PubMed ID: 35367242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract.
    Yono M; Yamamoto Y; Yoshida M; Ueda S; Latifpour J
    Life Sci; 2007 Jun; 81(3):218-22. PubMed ID: 17574276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotension II receptor 1 blocker modifies the expression of apoptosis-related proteins and transforming growth factor-beta1 in prostate tissue of spontaneously hypertensive rats.
    Yu W; Zhao YY; Zhang ZW; Guo YL; Jin J
    BJU Int; 2007 Nov; 100(5):1161-5. PubMed ID: 17784886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of losartan on prostatic hyperplasia in spontaneous hypertension rats and its pathophysiological mechanism].
    Shen F; Dong LN; Zhang XY; Zhao XK; Zeng XF; Qu XB
    Zhonghua Nan Ke Xue; 2012 Jul; 18(7):600-5. PubMed ID: 22994044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of silodosin and tadalafil on bladder dysfunction in spontaneously hypertensive rats: Possible role of bladder blood flow.
    Nagao Y; Shimizu S; Kurabayashi A; Shimizu T; Tsuda M; Higashi Y; Fujieda M; Saito M
    Int J Urol; 2020 Mar; 27(3):258-265. PubMed ID: 31944397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis.
    Sugimoto M; Zhang X; Ueda N; Tsunemori H; Taoka R; Hayashida Y; Hirama H; Miyauchi Y; Matsuoka Y; Naito H; Osaki Y; Kekehi Y
    BMC Urol; 2019 Oct; 19(1):99. PubMed ID: 31646996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
    Yokoyama O; Ozeki A; Suzuki N; Murakami M
    Int J Urol; 2018 Mar; 25(3):240-245. PubMed ID: 29094398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single treatment with tadalafil on blood flow in lower urinary tract tissues in rat models of bladder overdistension/emptying and abdominal aorta clamping/release.
    Yoshinaga R; Kawai Y; Oka M; Fuchikami C; Oyama T
    Eur J Pharmacol; 2015 May; 754():92-7. PubMed ID: 25697472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
    Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of nerve growth factor expression in the prostate tissue of spontaneously hypertensive rats].
    Chen ZP; Zhou HL; Cao LS; Gao R
    Zhonghua Nan Ke Xue; 2011 Sep; 17(9):781-4. PubMed ID: 21961236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.